Statistics

Total Visits

Views
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo518

Total Visits Per Month

January 2026February 2026March 2026April 2026May 2026June 2026July 2026
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo1724132637337

File Visits

Views
2021 RAL cancers.pdf190

Top country views

Views
United States156
Germany108
Ireland73
Singapore37
Hong Kong24
Brazil23
United Kingdom19
Japan12
South Korea10
Vietnam10

Top cities views

Views
Frankfurt am Main100
Dublin73
Ashburn46
Hong Kong20
Council Bluffs15
London14
San Jose13
Singapore12
Social Circle10
Seoul9